High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directions.

Oncologist · 2024 · PMC11379638 · PMID 39096189

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Despite the topline failure of ImVigor10, a strong trend was noted in the exploratory analysis for adjuvant therapy in MRD-positive patients.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.